CD19 CAR T Cells in Patients With Relapsed or Refractory CD19 Positive B-cell Lymphoma

NCT03029338 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Lymphomas Non-Hodgkin's B-Cell
Relapse

Interventions

BIOLOGICAL: CD19 CAR T cells

Sponsor

Institute of Hematology & Blood Diseases Hospital, China

Collaborators

Juventas Cell Therapy Ltd.